Clinical Trials Logo

Coronary Disease clinical trials

View clinical trials related to Coronary Disease.

Filter by:

NCT ID: NCT02241239 Recruiting - Clinical trials for Coronary Heart Disease and Stroke

A Comparison of the Estimates of Fuwai and Reynolds Risk Model

Start date: August 2014
Phase: N/A
Study type: Observational

There are many risk prediction models. And their estimates are different. This study aimed to investigate the differences between the estimates of Fuwai and Reynolds risk model in Chinese, and investigate the reason for the differences.

NCT ID: NCT02234804 Recruiting - Coronary Disease Clinical Trials

The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study

DOCTOR Recross
Start date: July 2013
Phase: N/A
Study type: Interventional

Prospective, controlled, double randomized, non-blinded, multicenter, investigator initiated, academic superiority trial comparing optical coherence tomography (OCT) guided vs. angiography guided wire recrossing in jailed side branches (SB) (1. randomization 1:1)(superiority) and comparing Medtronic Resolute Integrity and Xience Prime for stent strut apposition in the SB ostium (2. randomization 1:1) (superiority). Acute primary endpoint and 30 days clinical follow-up. Hypothesis: OCT guided wire recrossing in bifurcation stenting results in less malapposed struts in the segment facing the SB ostium. Secondary hypothesis: Treatment by Medtronic Resolute Integrity stent results in less malapposed struts at the bifurcation segment compared to treatment by the Abbott Xience Prime stent.

NCT ID: NCT02232360 Recruiting - Clinical trials for Coronary Artery Disease

Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone

Start date: January 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine effects of combination therapy with rosuvastatin and fenofibrate on atheromatous plaques and its tissue characteristics of de novo coronary lesions with intermediate stenosis in patient with coronary artery disease, compared with rosuvastatin alone therapy.

NCT ID: NCT02219594 Recruiting - Clinical trials for Coronary Heart Disease

The Comparative Study of OCT,Gemstone CT and 320-detector Row Spiral CT for Evaluating Restenosis of Coronary Artery Stent

Start date: June 2014
Phase: N/A
Study type: Interventional

In-stent restenosis is a major reason of coronary heart disease recurrence .Even in drug eluting stent(DES), Restenosis rate could be up to 10% in diabetes and complex lesions though it was about 3-5% in general. It is particularly important that in-stent restenosis after implantation was early diagnosed and detected. The evaluation of OCT imaging is more accurate for narrow area calculation, more clear for narrow organization structure and more specific for detecting tissue types.It is currently the best way for restenosis histologic diagnosis.But it has many weakness such as the higher cost,an invasive test, expensive instrument, relatively complicated to operate,and etc.In this study, OCT image was regard as the "gold standard" of stent restenosis. The improvement of spatial resolution of Gemstone CT can effectively improve the imaging quality and the measurement's accuracy of coronary artery stents.The diagnostic value of in-stent restenosis of Gemstone CT is higher than of the 320-detector row spiral CT. To a certain extent, the gemstone CT can replace OCT for examining the in-stent restenosis. This study will examine the degree of in-stent restenosis by the gemstone CT and the 320-detector row spiral CT and compare the two ways on the basis of the result of OCT.

NCT ID: NCT02216058 Recruiting - Clinical trials for Coronary Artery Disease

Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease

Start date: April 2013
Phase: N/A
Study type: Interventional

A prospective, multicenter study is preformed to evaluate the safety and efficacy of NOYA CoCr biodegradable coating sirolimus-eluting stents in treating coronary artery lesions.

NCT ID: NCT02213939 Recruiting - Coronary Disease Clinical Trials

Clinical Impact of Cytokine in Cardiac Surgery

Start date: August 2014
Phase: N/A
Study type: Observational

Cardiac surgery leeds to a systematic inflammatory response induced by the surgical trauma and the use of the cardiopulmonary bypass (CPB). Activation of inflammatory cascades can cause a systemic inflammatory response syndrome (SIRS) which is associated with increased morbidity and mortality. Therefore, strategies to reduce the inflammatory response have a potential benefit for cardiac surgery patients. The clinical benefit of reducing proinflammatory cytokines such as IL-6, Il-8 and TNF-a with the use of a cytokine adsorbing circuit (Cytosorb) during CBP remains unclear. Therefore, the investigators conduct this prospective, observational pilot study to determine the clinical impact of the use of a cytokine adsorbing circuit during CBP.

NCT ID: NCT02208388 Recruiting - Coronary Disease Clinical Trials

Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial

PERFUSERCT
Start date: August 12, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate safety and effectiveness of CTP(computed tomography perfusion) guided revascularization vs FFR(Fractional flow reserve) guided revascularization

NCT ID: NCT02186093 Recruiting - Clinical trials for Coronary Artery Disease

Clinical, Physiological and Prognostic Implication of Microvascular Status

Start date: April 2009
Phase: N/A
Study type: Observational [Patient Registry]

There are several physiologic parameters in evaluating cardiovascular disease. This study will reveal which parameter is the most proper value in predicting disease severity and risk factors of patients.

NCT ID: NCT02180178 Recruiting - Clinical trials for Coronary Artery Disease

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry

MICAT
Start date: September 2013
Phase:
Study type: Observational [Patient Registry]

Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.

NCT ID: NCT02174939 Recruiting - Clinical trials for Coronary Artery Disease

Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease

Start date: February 2014
Phase: Phase 4
Study type: Interventional

1. The number and function of circulating endothelial progenitor cells (EPCs) are inversely associated with coronary risk factors and atherosclerotic diseases such as coronary artery disease (CAD) and cardiovascular high risk. 2. This double-blind, randomized, placebo-controlled trial to evaluate the effects of cilostazol on human early EPCs and endothelial function as well as the potential mechanisms of action in patients with CAD and cardiovascular high risk.